Mikhail Blagosklonny Is Applauded For His Input In Fighting Cancer and Age-Related Diseases

August 19, 2017

Being a life threatening disease in the medical sector, cancer has attracted the attention of not only researchers and oncologists but also donors. It is projected that most of these individuals have converged to fight the disease and its effects on the affected. The primary reason for this convergence is coming up with treatment methods as well as therapies in the long run. One scientist who is applauded for his tremendous input in the field is Mikhail Blagosklonny. He believes that the best cancer treatment involves extensive research and he has put intense work to it.

Specialty

As a specialist in biology and cancer, Blagosklonny understands the importance of enlightening the masses with the knowledge behind cancer and its effects to the body. Mikhail has strong academic credentials in research. This has enabled him to make fundamental contributions in the field of cancer and age related diseases. As a scholar, he has studied the replication of cancer in the human body and its effects to the daily lives of the affected and infected. His contribution to this field is highly regarded as a revolutionizing treatment for cancer.

Research

Blagosklonny is a prominent oncologist who focuses on science. Since his journey in this field began, he has authored over 150 articles with the same content. Additionally, he has actively co-authored multiple book chapters as well as research reviews based on cellular as well as molecular biology. These studies are based on the understanding of cancer cells, their cycle as well as behavior in body cells. From apoptosis and autophagy, Mikhail’s input in the field of medicine is regarded as a transformational treatment therapy. His works are vastly cited in several articles as not only helpful but also insightful.

TOR Signaling

On cancer, Mikhail argues that TOR Signaling also known as theory of rapamycin is known for prolonging life. This is possible when apoptosis is inhibited. The processes play a vital role in slowing down the aging rate of a human cell. This in turn delays the onset of diseases that root from old age. Blagosklonny proposed that the over expression of target of rapamycin signaling had a huge inhibition to autophagy. This led to the growth of cancerous tumors. It therefore, means that its regulation can assist in cancer treatment. Mikhail is confident that with a detailed understanding of these processes, there will be a treatment solution to cancer and age-related diseases.

Career and Education

On education and career, Mikhail is a role model with vast experience. His experience extends further into research. Presently, Mikhail is a professor of oncology at the Roswell Cancer Institute of Research. He was appointed in 2009. It is projected that his past experiences played a key role in influencing his appointment. Having worked at Ordway Institute of Research, it was normal for the management to trust him with a leadership position. At the New York Medical College, he was appointed the associate professor. The alumnus of First Pavlov University in St. Petersburg is a leader in nature. He presently leads the editorial department of Oncotarget. He is focused on finding treatment methods and therapies for cancer.